NDC 63539-121

Caverject Impulse

Alprostadil

Caverject Impulse is a Intracavernous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceuticals. The primary component is Alprostadil.

Product ID63539-121_0dcd3231-552e-4243-bbc9-b8ed733d3ff4
NDC63539-121
Product TypeHuman Prescription Drug
Proprietary NameCaverject Impulse
Generic NameAlprostadil
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRACAVERNOUS
Marketing Start Date2014-05-04
Marketing CategoryNDA / NDA
Application NumberNDA021212
Labeler NameU.S. Pharmaceuticals
Substance NameALPROSTADIL
Active Ingredient Strength10 ug/.5mL
Pharm ClassesGenitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [CS],Venous Vasodilation [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 63539-121-11

2 SYRINGE in 1 CARTON (63539-121-11) > .5 mL in 1 SYRINGE (63539-121-10)
Marketing Start Date2014-05-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63539-121-11 [63539012111]

Caverject Impulse INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA021212
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-05-04

NDC 63539-121-10 [63539012110]

Caverject Impulse INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA021212
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-05-04

Drug Details

Active Ingredients

IngredientStrength
ALPROSTADIL10 ug/.5mL

OpenFDA Data

SPL SET ID:d8f85a7e-becb-4e15-9829-40e8f359140a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 763474
  • 763470
  • 763473
  • 763472
  • Pharm Class PE
  • Genitourinary Arterial Vasodilation [PE]
  • Venous Vasodilation [PE]
  • PHarm Class EPC
  • Prostaglandin Analog [EPC]
  • Prostaglandin E1 Agonist [EPC]
  • NUI Code
  • N0000009059
  • N0000000106
  • N0000175454
  • N0000007706
  • N0000009911
  • N0000180189
  • Pharmacological Class

    • Genitourinary Arterial Vasodilation [PE]
    • Prostaglandin Analog [EPC]
    • Prostaglandin E1 Agonist [EPC]
    • Prostaglandin Receptor Agonists [MoA]
    • Prostaglandins [Chemical/Ingredient]
    • Venous Vasodilation [PE]
    • Prostaglandins [CS]
    • Genitourinary Arterial Vasodilation [PE]
    • Prostaglandin Analog [EPC]
    • Prostaglandin E1 Agonist [EPC]
    • Prostaglandin Receptor Agonists [MoA]
    • Prostaglandins [CS]
    • Venous Vasodilation [PE]

    NDC Crossover Matching brand name "Caverject Impulse" or generic name "Alprostadil"

    NDCBrand NameGeneric Name
    0009-5181Caverject ImpulseAlprostadil
    0009-5182Caverject ImpulseAlprostadil
    63539-121Caverject ImpulseAlprostadil
    63539-221Caverject ImpulseAlprostadil
    0703-1501AlprostadilAlprostadil
    0009-3701CaverjectAlprostadil
    0009-7686CaverjectAlprostadil
    52244-010Edexalprostadil
    52244-020Edexalprostadil
    52244-040Edexalprostadil
    0037-8110MUSEAlprostadil
    0037-8120MUSEAlprostadil
    0037-8130MUSEAlprostadil
    0037-8140MUSEAlprostadil
    0009-0215PROSTINalprostadil
    0009-3169PROSTINalprostadil

    Trademark Results [Caverject Impulse]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CAVERJECT IMPULSE
    CAVERJECT IMPULSE
    85951408 4804504 Live/Registered
    Pharmacia & Upjohn Company LLC
    2013-06-05
    CAVERJECT IMPULSE
    CAVERJECT IMPULSE
    76169259 not registered Dead/Abandoned
    Pharmacia & Upjohn Company
    2000-11-21
    CAVERJECT IMPULSE
    CAVERJECT IMPULSE
    76150975 2660383 Dead/Cancelled
    PHARMACIA & UPJOHN COMPANY LLC
    2000-10-20

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.